"Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease." Neurology
99.22
(2022):
e2504-e2516.
Web. 30 Mar. 2023.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
